Parenteral Drug Association

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1023/a:1016212804288 A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
https://doi.org/10.1038/374546a0 CpG motifs in bacterial DNA trigger direct B-cell activation
https://doi.org/10.1002/ajmg.a.61434 The sixth international RASopathies symposium: Precision medicine—From promise to practice
https://doi.org/10.1016/j.xphs.2019.10.064 Shocking Data on Parcel Shipments of Protein Solutions
https://doi.org/10.5731/pdajpst.2018.008771 The Impact of Quality Culture on Operational Performance—An Empirical Study from the Pharmaceutical Industry
https://doi.org/10.1080/16258312.2024.2384828 Reverse logistics capabilities and supply chain performance in a developing country context
https://doi.org/10.5731/pdajpst.2014.00954 A Risk-Based Auditing Process for Pharmaceutical Manufacturers
https://doi.org/10.1016/j.xphs.2024.08.018 Is access to leadership roles contributing to the gender pay gap in the pharmaceutical sciences?
https://doi.org/10.1002/chp.20087 A case study in experiential learning: Pharmaceutical cold chain management on wheels *
https://doi.org/10.1007/b104242 Types of Filtration
https://doi.org/10.1002/art.40910 Variability in Antinuclear Antibody Testing to Assess Patient Eligibility for Clinical Trials of Novel Treatments for Systemic Lupus Erythematosus
https://doi.org/10.5731/pdajpst.2014.00957 Proceedings of the 2011 Viral Clearance Symposium (South San Francisco, CA)
https://doi.org/10.1331/japha.2009.08140 Integration of temperature-controlled requirements into pharmacy practice
https://doi.org/10.5731/pdajpst.2018.009027 Achieving “Zero” Defects for Visible Particles in Injectables
https://doi.org/10.4049/jimmunol.188.supp.43.16 The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria (43.16)
An interpretation of the pharmaceutical industry survey of current sterile filtration practices.
https://doi.org/10.1007/bf01183840 B-spline FIR filters
https://doi.org/10.5731/pdajpst.2019.010645 Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations
https://doi.org/10.1016/0003-9861(91)90173-g Long-term effects of insulin on the enzyme activity and messenger RNA of glycogen synthase in rat hepatoma H4 cells: An effect of insulin on glycogen synthase mRNA stability
https://doi.org/10.1080/13550280490499506 Developmental alterations in serotoninergic neurotransmission in Borna disease virus (BDV)-infected rats: A multidisciplinary analysis
U.S. v. Barr Laboratories: a technical perspective.
https://doi.org/10.5731/pdajpst.2015.01053 Proceedings of the 2013 Viral Clearance Symposium (Princeton, NJ)
Regulatory aspects of isolation/barrier technology.
https://doi.org/10.3934/mbe.2015.12.1277 Oncogene-tumor suppressor gene feedback interactions and their control
https://doi.org/10.1096/fasebj.22.1_supplement.674.9 Unique functions of the type II interleukin 4 receptor revealed in mice lacking the interleukin 13 receptor α1 chain
https://doi.org/10.5731/pdajpst.2016.006874 Introduction: Proceedings of the 2015 Viral Clearance Symposium
https://doi.org/10.5731/pdajpst.2019.001118 PDA Responds to the Novel Coronavirus Situation
https://doi.org/10.4049/jimmunol.186.supp.110.3 Heme oxygenase-1 induction stimulates host defense mechanism against infections (110.3)
Carleton's corner. Should the United States pharmacopeia define manufacturing process limits?
https://doi.org/10.1007/978-1-4899-1828-4_46 Serovar Specific Differences in Salmonella Survival within Macrophage Cells
https://doi.org/10.7883/yoken1952.51.supplement1_s90 Salmonella typhi Entry into Intestinal Epithelial Cells
Introduction to the issues: new potential contaminants and other exogenous agents.
PDA comments to USP on 'proposed changes to <71> sterility tests'.
https://doi.org/10.4049/jimmunol.182.supp.82.2 Role of TOSO in activation induced cell death of human T- and NK cells (82.2)
https://doi.org/10.4049/jimmunol.184.supp.136.16 Differential IFN signature for TLR7 and 9 agonists (136.16)
https://doi.org/10.1186/1742-4690-2-s1-p34 HIV Escape From Peptide Fusion Inhibitors
https://doi.org/10.4049/jimmunol.188.supp.68.2 Role of granulysin in MDP-induced PGE2 production in human monocytes (68.2)
https://doi.org/10.4049/jimmunol.190.supp.54.17 Efficacy of a prime/boost regimen including BCG and recombinant protein in an HN878 challenge of C57BL/6 mice (P4296)
https://doi.org/10.5731/pdajpst.2015.01048 PDA Single-Use Systems Cross-Organizational Workshop--Meeting Summary, May 14, 2014--PDA Global Headquarters, Bethesda, MD
https://doi.org/10.1097/00002371-199508000-00021 RECEPTOR FOR INTERLEUKIN 13
https://doi.org/10.1002/qaj.220 The International Association for Pharmaceutical Science and Technology
https://doi.org/10.4049/jimmunol.190.supp.112.15 Multiple pathways are employed by TLR and NOD agonists to induce PGE2 production in primary human monocytes and macrophages (P4163)
https://doi.org/10.1096/fasebj.24.1_supplement.200.1 Imaging Brain Chemistry in Diseases of Addiction
https://doi.org/10.1158/1538-7445.am2013-lb-38 Abstract LB-38: VPS34 lipid kinase activity is positively regulated by Src phosphorylation and is required for Src-mediated cellular transformation.
https://doi.org/10.1158/1538-7445.am10-323 Abstract 323: Early detection of cytogenetic switch from monoallelic to biallelic 13q14 deletion using BCL-2 index in CLL
Insect cells: introduction to the issues.
Introduction to the issues: assays for screening contamination.
PDA letter to the FDA regarding process simulation testing.
https://doi.org/10.1096/fasebj.21.6.lb86-d Ascorbic acid in pharmacologic concentrations selectively kills cancer cells
https://doi.org/10.1096/fasebj.22.1_supplement.1070.23 Plasmacytoid Dendritic Cells both produce interferon‐λ and respond to interferon‐λ stimulation
https://doi.org/10.5281/zenodo.2380911 IN-PROCESS QUALITY CONTROL: A SYSTEMATIC APPROACH TO CONTROL CRITICAL STEPS IN FINISHED PHARMACEUTICAL PRODUCTS
https://doi.org/10.5281/zenodo.1006759 In-Process Quality Control: A Systematic Approach To Control Critical Steps In Finished Pharmaceutical Products
https://doi.org/10.1096/fasebj.30.1_supplement.897.3 FDA's Evaluations of GRAS Food Ingredients
https://doi.org/10.1182/blood-2025-3145 Impact of whole blood amustaline pathogen inactivation on plasma coagulation factor activity; Mechanism of action
https://doi.org/10.4049/jimmunol.186.supp.115.9 Characterization of antigen-specific CD4+CD25+ regulatory T-cells expanded with IL-2/IL-2mAb complexes in NOD mice (115.9)
https://doi.org/10.4049/jimmunol.186.supp.147.7 Human multipotent stromal cells inhibit the activation of antigen specific murine CD4+ and CD8+ T cells (147.7)
https://doi.org/10.4049/jimmunol.184.supp.37.1 Three functional regions in human tonsil distinguished by in situ gene expression (37.1)